These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37176029)

  • 1. The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome.
    Lu Z; Li Y; Chowdhury N; Yu H; Syn WK; Lopes-Virella M; Yilmaz Ö; Huang Y
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of acid sphingomyelinase by imipramine abolishes the synergy between metabolic syndrome and periodontitis on alveolar bone loss.
    Li Y; Lu Z; Zhang L; Kirkwood CL; Kirkwood KL; Lopes-Virella MF; Huang Y
    J Periodontal Res; 2022 Jan; 57(1):173-185. PubMed ID: 34748647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.
    Li Y; Lu Z; Zhang X; Yu H; Kirkwood KL; Lopes-Virella MF; Huang Y
    J Dent Res; 2015 Feb; 94(2):362-70. PubMed ID: 25503900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipid metabolism in non-alcoholic fatty liver diseases.
    Régnier M; Polizzi A; Guillou H; Loiseau N
    Biochimie; 2019 Apr; 159():9-22. PubMed ID: 30071259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.
    Lu Z; Li Y; Syn WK; Wang Z; Lopes-Virella MF; Lyons TJ; Huang Y
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E131-E144. PubMed ID: 31821039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro.
    Li Y; Lu Z; Ru JH; Lopes-Virella MF; Lyons TJ; Huang Y
    Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E745-E757. PubMed ID: 29989851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.
    Jani S; Da Eira D; Stefanovic M; Ceddia RB
    J Physiol; 2022 Sep; 600(18):4137-4151. PubMed ID: 35974660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR40 deficiency worsens metabolic syndrome-associated periodontitis in mice.
    Li Y; Lu Z; Kirkwood CL; Kirkwood KL; Wank SA; Li AJ; Lopes-Virella MF; Huang Y
    J Periodontal Res; 2023 Jun; 58(3):575-587. PubMed ID: 36807310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism.
    Li F; Zhang Z; Bai Y; Che Q; Cao H; Guo J; Su Z
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    Lu Z; Li Y; Li AJ; Syn WK; Wank SA; Lopes-Virella MF; Huang Y
    PLoS One; 2022; 17(11):e0277251. PubMed ID: 36331958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
    Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate.
    Lu Z; Li Y; Brinson CW; Kirkwood KL; Lopes-Virella MF; Huang Y
    Oral Dis; 2017 Mar; 23(2):210-218. PubMed ID: 27753178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: Targeting ferroptosis and lipid metabolism disorders.
    Wang H; Shan C; Guo G; Ning D; Miao F
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113025. PubMed ID: 39243559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
    Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
    Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
    Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
    Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.